Editing Food and Drug Administration (section)

=== White Oak Federal Research Center ===
Since 1990, the FDA has had employees and facilities on {{Convert|130|acre|ha|abbr=off}} of the White Oak Federal Research Center in the [[White Oak, Maryland|White Oak]] area of [[Silver Spring, Maryland]].<ref name="White Oak" /><ref name="coordinates">Coordinates of FDA Headquarters at White Oak, Maryland: {{coord|39.0353363|-76.9830894|region:US-MD_type:landmark|format=dms|name=FDA Headquarters at White Oak, Maryland}}</ref> In 2001, the [[General Services Administration]] (GSA) began new construction on the campus to consolidate the FDA's 25 existing operations in the [[Washington metropolitan area]], its headquarters in [[Rockville, Maryland|Rockville]], and several fragmented office buildings. The first building, the Life Sciences Laboratory, was dedicated and opened with 104 employees in December 2003. {{as of|December 2018|post=,}} the FDA campus has a population of 10,987 employees housed in approximately {{Convert|3800000|sqft|m2|abbr=off}} of space, divided into ten offices and four laboratory buildings. The campus houses the [[Commissioner of the Food and Drug Administration|Office of the Commissioner]] (OC), the Office of Regulatory Affairs (ORA),&nbsp; the [[Center for Drug Evaluation and Research]] (CDER), the [[FDA Center for Devices and Radiological Health|Center for Devices and Radiological Health]] (CDRH), the [[Center for Biologics Evaluation and Research]] (CBER) and offices for the [[Center for Veterinary Medicine]] (CVM).<ref name="White Oak"/>

With the passing of the FDA Reauthorization Act of 2017, the FDA projects a 64% increase in employees to 18,000 over the next 15 years and wants to add approximately {{Convert|1600000|sqft|m2|abbr=off}} of office and special use space to their existing facilities. The [[National Capital Planning Commission]] approved a new master plan for this expansion in December 2018,<ref>{{Cite web |title=FDA White Oak Master Plan |url=https://www.ncpc.gov/projects/MP201/ |access-date=October 3, 2020 |website=National Capital Planning Commission |language=en |archive-date=October 9, 2020 |archive-url=https://web.archive.org/web/20201009032259/https://www.ncpc.gov/projects/MP201/ |url-status=live}}</ref> and construction is expected to be completed by 2035, dependent on GSA appropriations.<ref>{{cite journal |url=https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm057328.htm |title=White Oak Campus Project Schedule |journal=FDA |date=October 8, 2015 |access-date=December 16, 2019 |archive-date=April 23, 2019 |archive-url=https://web.archive.org/web/20190423052101/https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm057328.htm |url-status=live}}</ref>